These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22457198)

  • 1. Inhibition of sclerostin by systemic treatment with sclerostin antibody enhances healing of proximal tibial defects in ovariectomized rats.
    McDonald MM; Morse A; Mikulec K; Peacock L; Yu N; Baldock PA; Birke O; Liu M; Ke HZ; Little DG
    J Orthop Res; 2012 Oct; 30(10):1541-8. PubMed ID: 22457198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
    Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
    Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats.
    Liu Y; Rui Y; Cheng TY; Huang S; Xu L; Meng F; Lee WY; Zhang T; Li N; Li C; Ke H; Li G
    Calcif Tissue Int; 2016 Mar; 98(3):263-74. PubMed ID: 26603303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
    Li X; Niu QT; Warmington KS; Asuncion FJ; Dwyer D; Grisanti M; Han CY; Stolina M; Eschenberg MJ; Kostenuik PJ; Simonet WS; Ominsky MS; Ke HZ
    Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.
    Zhang D; Hu M; Chu T; Lin L; Wang J; Li X; Ke HZ; Qin YX
    Bone; 2016 Jun; 87():161-8. PubMed ID: 26868528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin antibody treatment improves implant fixation in a model of severe osteoporosis.
    Virdi AS; Irish J; Sena K; Liu M; Ke HZ; McNulty MA; Sumner DR
    J Bone Joint Surg Am; 2015 Jan; 97(2):133-40. PubMed ID: 25609440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of sclerostin antibody plus parathyroid hormone (1-34) on bone formation in ovariectomized rats.
    Wu J; Cai XH; Qin XX; Liu YX
    Z Gerontol Geriatr; 2018 Jul; 51(5):550-556. PubMed ID: 28364259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
    Chen H; Xu X; Liu M; Zhang W; Ke HZ; Qin A; Tang T; Lu E
    Bone; 2015 Jul; 76():141-8. PubMed ID: 25868799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
    Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
    Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin antibody stimulates bone regeneration after experimental periodontitis.
    Taut AD; Jin Q; Chung JH; Galindo-Moreno P; Yi ES; Sugai JV; Ke HZ; Liu M; Giannobile WV
    J Bone Miner Res; 2013 Nov; 28(11):2347-56. PubMed ID: 23712325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats.
    Suen PK; He YX; Chow DH; Huang L; Li C; Ke HZ; Ominsky MS; Qin L
    J Orthop Res; 2014 Aug; 32(8):997-1005. PubMed ID: 24782158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model.
    Virk MS; Alaee F; Tang H; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2013 Apr; 95(8):694-701. PubMed ID: 23595067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats.
    Feng G; Chang-Qing Z; Yi-Min C; Xiao-Lin L
    Int Immunopharmacol; 2015 Jan; 24(1):7-13. PubMed ID: 25479724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
    Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin-Neutralizing Antibody Enhances Bone Regeneration Around Oral Implants.
    Yu SH; Hao J; Fretwurst T; Liu M; Kostenuik P; Giannobile WV; Jin Q
    Tissue Eng Part A; 2018 Nov; 24(21-22):1672-1679. PubMed ID: 29921173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody.
    Ominsky MS; Niu QT; Li C; Li X; Ke HZ
    J Bone Miner Res; 2014 Jun; 29(6):1424-30. PubMed ID: 24967455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of systemic treatment with a sclerostin neutralizing antibody on bone repair in a rat femoral defect model.
    Alaee F; Virk MS; Tang H; Sugiyama O; Adams DJ; Stolina M; Dwyer D; Ominsky MS; Ke HZ; Lieberman JR
    J Orthop Res; 2014 Feb; 32(2):197-203. PubMed ID: 24600701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin antibody enhances bone formation in a rat model of distraction osteogenesis.
    McDonald MM; Morse A; Birke O; Yu NYC; Mikulec K; Peacock L; Schindeler A; Liu M; Ke HZ; Little DG
    J Orthop Res; 2018 Apr; 36(4):1106-1113. PubMed ID: 28884841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model.
    Tian X; Jee WS; Li X; Paszty C; Ke HZ
    Bone; 2011 Feb; 48(2):197-201. PubMed ID: 20850580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of disassociation of bone formation signals with bone mass and bone strength in sclerostin antibody treated ovariectomized rats.
    Ma YL; Hamang M; Lucchesi J; Bivi N; Zeng Q; Adrian MD; Raines SE; Li J; Kuhstoss SA; Obungu V; Bryant HU; Krishnan V
    Bone; 2017 Apr; 97():20-28. PubMed ID: 27939957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.